Certified by Founder Lodge
Pinnacle Medicines
- ND
START UP
1 Disclosed Funding Rounds $89,000,000
0 Participating Investments
-
Founded date
2024
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Pinnacle Medicines is an emerging peptide drug discovery company based in Doylestown, Pennsylvania. Pinnacle has raised substantial Series A funding led by OrbiMed and Qiming Venture Partners
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 27 ,2026 | Series B | $89,000,000 |
OrbiMed
Foresite Capital
Logos Capital
Quan Capital 泉创资本
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Kubera Health | $6,500,000 | (May 29, 2026)
Solstice | $21,000,000 | (May 29, 2026)
Volt Harbor Inc. | $2,000,000 | (May 29, 2026)
Psilera | $8,800,000 | (May 29, 2026)
Crimson | $2,500,000 | (May 29, 2026)
